Faculty

Maria Daniela Hurtado Andrade, M.D., Ph.D.

Clinical Studies

A Multicenter, Randomized, Double-blind, Sham-controlled study for Assessing the Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals with Type II Diabetes (ReCET Study) Rochester, Minn., Jacksonville, Fla.
The purpose of this study is to demonstrate that Re-Cellularization therapy is superior to sham control for improving glycemic control in adults with type 2 diabetes inadequately controlled on non-insulin glucose-lowering medications.
A Novel Precision Medicine Approach For Obesity: A Randomized, Multi-Center Trial Rochester, Minn.
The purpose of this study is to test the effectiveness of semaglutide 2.4 mg SQ weekly in patients with obesity with a positive MyPhenome test for abnormal postprandial satiety compared to patients with obesity with a negative MyPhenome test for abnormal postprandial satiety.

A Novel Precision Medicine Approach For Obesity: A Randomized, Multi-Center Trial Jacksonville, Fla.
The purpose of this study is to test the effectiveness of semaglutide 2.4 mg SQ weekly in patients with obesity with a positive MyPhenome test for abnormal postprandial satiety compared to patients with obesity with a negative MyPhenome test for abnormal postprandial satiety.

Correlation Between Ovarian Axis Hormones and Adrenal Androgens and Measurements of Satiation, Postprandial Satiety, and Hunger in Pre- and Post-menopausal Women Rochester, Minn.
The purpose of this study is to determine the correlation between ovarian axis hormones and adrenal androgens and changes in satiation, postprandial satiety, and hunger in pre- and post-menopausal women. Since differential hormone profile is considered an important underlying physiologic change through the menopausal transition, changes in ovarian sexual hormones and adrenal androgen levels may have an association with changes in satiation, postprandial satiety, and hunger.
Multi-omics and Virtual Phenotyping in patients with Obesity: Multi-center Biobank and Outcomes Registry La Crosse, Wis., Rochester, Minn., Jacksonville, Fla.
The purpose of this study is to establish a multi-center biobank and outcomes registry of at least 2000 patients with obesity that allows for a better understanding of demographic, clinical, and biological variables that predict the severity of the disease, the development of weight-related complications, and the weight loss and weight-related complications outcomes in response to obesity interventions.